LinkOPH

BARCELONA — Ophthalmologists need to learn more about microbes in order to better treat and understand ocular infections, according to a speaker. “We need basic science to tell us about that enemy that we are battling,” OSN Cornea/External Disease Board Member Terrence P. O’Brien, MD, told colleagues at the International Conference on Ocular Infections held jointly with the European Society of Cataract and Refractive Surgeons meeting. “Although there have been advances in laboratory models of ocular infection, we have not applied what we have learned in those models to new treatments that can help save the eye.”

Read more →

BARCELONA — Minimally invasive procedures have gained a role in the treatment of glaucoma and should be explored more and used more in the future, according to Norbert Pfeiffer, MD. “Minimally invasive procedures have enhanced our armamentarium,” Pfeiffer said, adding that, even though the procedures are not as efficacious as conventional surgery, they have fewer side effects and allow patients to reduce rather than eliminate the need for medications.

Read more →

DUBLIN–(BUSINESS WIRE)–Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near vision restoration announced that it has scheduled the remaining treatments for completing the second stage enrollment of its U.S. Food and Drug Administration (FDA) pivotal study, a significant milestone in the FDA approval process of its Presbia Flexivue Microlens™. The final surgeries will take place the week of September 7. This announcement was made at the Barcelona 2015 XXXIII Congress of

Read more →

A single-piece hydrophobic acrylic IOL was associated with a significant increase in posterior capsule opacification up to 3 years and stabilization between 3 years and 5 years, according to a study.The prospective study included 390 eyes of 390 patien…

Read more →